TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 45 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,100 | +2.0% | 11,767 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $205,076 | +83.9% | 11,349 | +27.9% | 0.00% | 0.0% |
| Q1 2023 | $111,496 | -12.5% | 8,870 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $127,439 | -14.5% | 8,693 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $149,000 | +20.2% | 8,725 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $124,000 | +77.1% | 8,486 | +102.7% | 0.00% | – |
| Q1 2022 | $70,000 | -30.7% | 4,186 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $101,000 | +2.0% | 4,480 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $99,000 | -27.7% | 4,614 | -2.3% | 0.00% | – |
| Q2 2021 | $137,000 | +17.1% | 4,724 | +30.3% | 0.00% | – |
| Q1 2021 | $117,000 | -20.9% | 3,626 | +1.5% | 0.00% | -100.0% |
| Q4 2020 | $148,000 | – | 3,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |